Physician profile
Ilan Waldman
NPI 1871711655
$7,176.71
in general payments reported to CMS, 2019-2025
51 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,268 · 2020: $837 · 2021: $315 · 2022: $1,064 · 2023: $1,487 · 2024: $1,133 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.41 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $859.00 | 2019-2020 | |
| Antares Pharma, INC. | $588.45 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $499.22 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $481.34 | 2019-2025 | |
| Astellas Pharma US INC | $453.33 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $413.73 | 2019-2024 | Provenge |
| Janssen Biotech, INC. | $353.55 | 2019-2025 | Erleada |
| Teleflex LLC | $350.69 | 2021-2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $279.03 | 2021-2024 | Prolaris, Myrisk |
| Abbvie INC. | $234.82 | 2019-2025 | Botox |
| Tolmar, INC. | $227.57 | 2023-2025 | Eligard |
| Urogen Pharma, INC. | $160.97 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $158.81 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $154.20 | 2019-2023 | Xiaflex |
| 180 Medical, INC. | $129.76 | 2022-2024 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilan Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.